A new law offering relief to Minamata disease patients cleared the Lower House Friday, a day after the ruling and opposition camps officially agreed to loosen the eligibility requirements for patients seeking compensation. The bill broadens the scope... ...full story at Japan Times
from Japan Times on Fri, Jul 03 2009
see also:
| 07 Jun 08 |
|
House of Commons adopts Layton's Kyoto Plus bill »
YouTube video With the passage of NDP Leader Jack Layton's private member's bill, The Climate Change Accountability Act (Bill C-377), Canada's House of Commons has become the first elected chamber in the world to adopt science-based targets to reduce greenhouse gas... |
| 03 Jul 09 |
|
Politics › Bill to offer relief to Minamata patients passes lower house » Japan Today The House of Representatives passed a bill Friday to offer financial relief to as many as 20,000 people suffering from Minamata mercury poisoning in the… |
| 06 Jul 09 |
|
Relief for Minamata victims » Japan Times The Upper House is likely to enact a bill that will offer financial relief to more sufferers of Minamata disease. It is expected to cover about 20,000 of some 30,000 people, mainly in Kumamoto and Kagoshima prefectures, who are seeking recognition as... |
| 08 Jul 09 |
|
Politics › Diet enacts legislation offering relief for Minamata disease patients » Japan Today The Diet enacted legislation Wednesday offering financial relief to Minamata disease patients who have remained unrecognized as victims of one of the country's worst cases… |
| 06 Nov 08 |
|
Bank bailout bill clears Lower House » Japan Times A bill to inject public funds into financial institutions to bolster their capital bases was passed by the House of Representatives at its plenary session Thursday. The so-called bank recapitalization bill cleared the Lower House by a majority vote of... |
| 20 Feb 09 |
|
Opposition bill lowers hepatitis patients' costs » Japan Times Four opposition parties jointly submitted a bill Friday to the Lower House that would greatly reduce medical costs that hepatitis B and C patients need to shoulder for expensive interferon treatment and antiviral medication. Last April, the government... |